Literature DB >> 28398677

Preparing for biological threats: Addressing the needs of pregnant women.

Amelia K Watson1, Sascha Ellington2, Christina Nelson2, Tracee Treadwell2, Denise J Jamieson2, Dana M Meaney-Delman2.   

Abstract

Intentional release of infectious agents and biological weapons to cause illness and death has the potential to greatly impact pregnant women and their fetuses. We review what is known about the maternal and fetal effects of seven biological threats: Bacillus anthracis (anthrax); variola virus (smallpox); Clostridium botulinum toxin (botulism); Burkholderia mallei (glanders) and Burkholderia pseudomallei (melioidosis); Yersinia pestis (plague); Francisella tularensis (tularemia); and Rickettsia prowazekii (typhus). Evaluating the potential maternal, fetal, and infant consequences of an intentional release of an infectious agent requires an assessment of several key issues: (1) are pregnant women more susceptible to infection or illness compared to the general population?; (2) are pregnant women at increased risk for severe illness, morbidity, and mortality compared to the general population?; (3) does infection or illness during pregnancy place women, the fetus, or the infant at increased risk for adverse outcomes and how does this affect clinical management?; and (4) are the medical countermeasures recommended for the general population safe and effective during pregnancy? These issues help frame national guidance for the care of pregnant women during an intentional release of a biological threat. Birth Defects Research 109:391-398, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  biologic; bioterrorism; biowarfare; infectious diseases; pregnant; threats

Mesh:

Substances:

Year:  2017        PMID: 28398677     DOI: 10.1002/bdr2.1016

Source DB:  PubMed          Journal:  Birth Defects Res            Impact factor:   2.344


  7 in total

1.  Plague and Pregnancy: Why Special Considerations Are Needed.

Authors:  Dana Meaney-Delman; Nadia L Oussayef; Margaret A Honein; Christina A Nelson
Journal:  Clin Infect Dis       Date:  2020-05-21       Impact factor: 9.079

2.  A surprising treatment response in a patient with rare isolated growth hormone deficiency, type IB.

Authors:  Jordan Yardain Amar; Kimberly Borden; Elizabeth Watson; Talin Arslanian
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-11-09

3.  Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques.

Authors:  Shantha Kodihalli; Andrew Emanuel; Teresa Takla; Yi Hua; Charles Hobbs; Ross LeClaire; Denise C O'Donnell
Journal:  PLoS One       Date:  2017-11-22       Impact factor: 3.240

4.  Case Report: Lyme Borreliosis and Pregnancy - Our Experience.

Authors:  Giusto Trevisan; Maurizio Ruscio; Nicola di Meo; Katiuscia Nan; Marina Cinco; Sara Trevisini; Patrizia Forgione; Serena Bonin
Journal:  Front Med (Lausanne)       Date:  2022-03-28

5.  Case Report: Gestational Melioidosis through Perinatal Transmission.

Authors:  José Y Rodríguez; Mónica G Huertas; Gerson J Rodríguez; Sandra Vargas-Otalora; Miguel A Benıtez-Peñuela; Kelin Esquea; Rafael Rios; Laura R Mendoza; Lorena Diaz; Jinnethe Reyes; Carlos A Álvarez-Moreno
Journal:  Am J Trop Med Hyg       Date:  2020-11       Impact factor: 2.345

Review 6.  Confronting the threat of bioterrorism: realities, challenges, and defensive strategies.

Authors:  Manfred S Green; James LeDuc; Daniel Cohen; David R Franz
Journal:  Lancet Infect Dis       Date:  2018-10-16       Impact factor: 25.071

7.  Disseminated melioidosis in early pregnancy - an unproven cause of foetal loss.

Authors:  Chee Yik Chang; Nina Lee Jing Lau; Bart J Currie; Yuwana Podin
Journal:  BMC Infect Dis       Date:  2020-03-06       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.